30 Years of Evidence
Join the experts’ corner
This page presents publications and webinars from around the globe. It includes evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and motion synchronization techniques for both the CyberKnife® and TomoTherapy® platforms. We update new papers on a regular basis. Please take a moment to explore the page and see the evidence we have collected to truly demonstrate how we are making a change to peoples’ lives.
Featured Content
ESTRO 2024
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Date: 2024
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Binnaz Yasar et al.
ESTRO 2024
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Date: 2024
Treatment Technique: IG-IMRT
Platform: TomoTherapy System
Author: Huang Wenhan et al.
ESTRO 2024
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Date: 2024
Treatment Technique: SBRT
Platform: CyberKnife System
Author: Esmeralda Scipilliti et al.
Evaluation of the New Independent Dose Calculation SciMoCa as Patient-Specific Quality Assurance in the CyberKnife Treatment of Brain Metastases and Lung Cancer
K Sakai, Y Nakajima, Y Suda, S Kito, Y Sato, K Yasui, Y Arai, T Takizawa, M Sato, Y Fujita | AAPM | 2022
A Dosimetric Comparison for Adaptive Cone-Beam CT and MRI Based Radiotherapy for Stereotactic Partial Breast Irradiation
D Parsons, L Chen, H Lee, Y Zhang, B Cai, T Zhuang, B Hrycushko, C Park, Y Gonzalez, X Zhong, J Visak, C Nwachukwu, N Kim, P Alluri, A Rahimi, M Lin | AAPM | 2022
Dosimetric Evaluation of the Treatment Goals Effectiveness of VMAT / Cyber Knife Versus IMPT When LET / Variable RBE Are Taken Into Consideration for Brain Tumors
H Kamal Sayed, Q Xu, J Fan | AAPM | 2022